spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MannKind 

 HSMN NewsFeed - 12 Jan 2023
Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 4 Sep 2018
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
Biopharmaceuticals Licensing
 HSMN NewsFeed - 24 Aug 2018
GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Mar 2016
Astellas Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2015
Galmed Pharmaceuticals Announces the Appointment of George Tonelli as Vice President of Clinical Operations
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 12 Jan 2015
MannKind CEO Alfred Mann to Transition to Executive Chairman; COO and President Hakan Edstrom Appointed to CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2014
Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin
Biopharmaceuticals Endocrinology Drug Delivery Licensing
 HSMN NewsFeed - 28 Dec 2010
MannKind Updates Status of New Drug Application for AFREZZA(R)
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 16 Mar 2009
MannKind Submits NDA for AFRESA for Treatment of Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Apr 2008
MannKind Addresses Pfizer's Announcement Regarding Exubera
Biopharmaceuticals Drug Delivery Endocrinology Oncology
 HSMN NewsFeed - 7 Jan 2008
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2007
Plexxikon Expands Management Team and Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2006
Type 2 Diabetes Patients on Technosphere Insulin Exhibited No Adverse Effect on Pulmonary Function with Significant HbA1c Reductions, and Showed Significant Weight Reduction Compared to Injected Insulin Analog
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 14 Sep 2006
MannKind Corporation Completes Patient Enrollment for the Major Phase 3 Safety Study of Technosphere(R) Insulin in Patients With Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 5

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 5 additional stories matching:
MannKind
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.